[CD47/SIRPa Summit 2020] A Novel MOA-reflective Bioassay for Quantifying Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis

File Name/Number:
CD47/SIRPa Summit 2020

Year:
2020


Jane Lamerdin, Ph.D.
Director R&D, Eurofins DiscoverX